A 72-year-old woman comes to the office due to a 6-month history of increasingly severe, i… — USMLE Step 2 CK

A 72-year-old woman comes to the office due to a 6-month history of increasingly severe, involuntary urinary leakage. She describes the urine as "just dripping out" when she transitions from sitting to standing or when walking around her home. The patient underwent a transobturator tape procedure 12 years ago that initially resolved her symptoms, but the leakage has recurred and is now worse. She reports no dysuria, hematuria, or pelvic pain. Medical history includes hypertension, osteoporosis, and well-controlled type 2 diabetes mellitus. Body mass index is $26 \text{ kg/m}^2$ . Pelvic examination reveals a well-supported vaginal apex with no anterior or posterior vaginal wall prolapse. A cotton swab (Q-tip) test demonstrates a resting angle of $5^\circ$ and a maximal straining angle of $15^\circ$ from the horizontal. Urodynamic evaluation shows a Valsalva leak point pressure of $45 \text{ cm H}_2\text{O}$ and a post-void residual volume of $20 \text{ mL}$ . Detrusor overactivity is absent during cystometry. Urinalysis is unremarkable. Which of the following is the most appropriate next step in management?

A
Midurethral sling placement
Urethral bulking agent injectionAnswer
C
Oral mirabegron therapy
D
Continence pessary placement
E
Intermittent self-catheterization

Answer

Urethral bulking agent injection

The correct answer is urethral bulking agent injection. This patient has stress urinary incontinence (SUI) caused by intrinsic sphincter deficiency (ISD), characterized by continuous or positional leakage, low Valsalva leak point pressure (

< 60 \text{ cm H}_2\text{O}

), and a lack of urethral hypermobility. The Q-tip test angle of

< 30^\circ

indicates a 'fixed' or non-hypermobile urethra. Because midurethral slings require a hypermobile urethra to compress against during increased intra-abdominal pressure, they are less effective in ISD without hypermobility. Therefore, urethral bulking agents (e.g., cross-linked collagen or polyacrylamide hydrogel), which increase tissue bulk to improve mucosal coaptation, are the preferred minimally invasive intervention, especially in patients with prior failed anti-incontinence surgeries.

Step-by-Step Solution

Analyze the patient's symptoms and prior surgical history.

The patient presents with severe, positional urinary leakage (dribbling when transitioning to standing) after a previously successful transobturator tape procedure.

Identifies the presentation as recurrent stress urinary incontinence (SUI), prompting evaluation for the specific underlying etiology.

Interpret the physical examination and urodynamic findings.

The Q-tip test reveals a maximal straining angle of

15^\circ

(indicating no urethral hypermobility). Urodynamics show a low Valsalva leak point pressure (

45 \text{ cm H}_2\text{O}

) with no detrusor overactivity and a normal post-void residual.

Differentiates between the two main causes of SUI: urethral hypermobility versus intrinsic sphincter deficiency (ISD). The findings definitively diagnose ISD with a 'fixed' or drainpipe urethra.

Select the most appropriate management based on the specific phenotype of SUI.

Urethral bulking agent injection is selected as the optimal intervention.

Because the urethra is already well-supported and fixed, creating a backboard with a standard midurethral sling will be ineffective. Bulking agents directly address the poor mucosal coaptation characteristic of ISD.

Key Concept

Intrinsic sphincter deficiency (ISD) without urethral hypermobility (Q-tip test

< 30^\circ

) is optimally managed with urethral bulking agents rather than standard midurethral slings, which require hypermobility to function effectively.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic